AU598443B2 - A method of treating hypoglycemia in vertebrates - Google Patents

A method of treating hypoglycemia in vertebrates

Info

Publication number
AU598443B2
AU598443B2 AU40636/85A AU4063685A AU598443B2 AU 598443 B2 AU598443 B2 AU 598443B2 AU 40636/85 A AU40636/85 A AU 40636/85A AU 4063685 A AU4063685 A AU 4063685A AU 598443 B2 AU598443 B2 AU 598443B2
Authority
AU
Australia
Prior art keywords
manganese
alpha
insulin
coa
isoleucine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40636/85A
Other languages
English (en)
Other versions
AU4063685A (en
Inventor
Vernon Erk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4063685A publication Critical patent/AU4063685A/en
Application granted granted Critical
Publication of AU598443B2 publication Critical patent/AU598443B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AU40636/85A 1984-03-01 1985-03-01 A method of treating hypoglycemia in vertebrates Ceased AU598443B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58528684A 1984-03-01 1984-03-01
US585286 1984-03-01

Publications (2)

Publication Number Publication Date
AU4063685A AU4063685A (en) 1985-09-24
AU598443B2 true AU598443B2 (en) 1990-06-28

Family

ID=24340799

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40636/85A Ceased AU598443B2 (en) 1984-03-01 1985-03-01 A method of treating hypoglycemia in vertebrates

Country Status (4)

Country Link
EP (1) EP0175714A4 (fr)
JP (1) JPS61501561A (fr)
AU (1) AU598443B2 (fr)
WO (1) WO1985003870A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752146A4 (fr) * 2004-05-19 2007-10-10 Ajinomoto Kk Agent thérapeutique pour le diabète
EP1935417A4 (fr) 2005-10-12 2009-06-10 Otsuka Pharma Co Ltd Composition à utiliser pour la prévention d'un état hypoglycémique

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873296A (en) * 1968-06-24 1975-03-25 Ashmead H H Increasing metals in biological tissue
US4298601A (en) * 1972-03-06 1981-11-03 Technutra, S.A. Method and formulations for the treatment of obesity
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
US4435424A (en) * 1980-07-15 1984-03-06 Massachusetts Institute Of Technology Process for improving vigor and mood in normal human patients

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same

Also Published As

Publication number Publication date
EP0175714A4 (fr) 1987-11-09
AU4063685A (en) 1985-09-24
JPS61501561A (ja) 1986-07-31
EP0175714A1 (fr) 1986-04-02
WO1985003870A1 (fr) 1985-09-12

Similar Documents

Publication Publication Date Title
Cynober et al. Action of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjects.
SKEIE et al. Branch-chain amino acids: their metabolism and clinical utility
US5240961A (en) Method of treating reduced insulin-like growth factor and bone loss associated with aging
Maddrey et al. Effects of keto analogues of essential amino acids in portal-systemic encephalopathy
ES2311117T3 (es) Combinacion de un inhibidor de dpp-iv y un compuesto ppar-alfa.
Viru Hormones Muscular Activity
Agharanya et al. Changes in catecholamine excretion after short-term tyrosine ingestion in normally fed human subjects
Takiyyuddin et al. Sympatho‐adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co‐release
AU599567B2 (en) Method of treating memory disorders of the elderly
AU598721B2 (en) Method of lowering blood sugar level in vertebrates
AU598443B2 (en) A method of treating hypoglycemia in vertebrates
Blaschko et al. Introduction Catecholamines 1922–1971
COHEN et al. False neurochemical transmitters: combined clinical staff conference at the National Institutes of Health
AU598444B2 (en) Method of prophylaxis or treatment of atherosclerosis
AU598722B2 (en) Method of treating depression in vertebrates
JPH03501027A (ja) エネルギー基質
CA1277904C (fr) Methode de traitement de la perte de memoire chez les vertebres
AU578456B2 (en) Tryptophans & manganese treats hypertension and toxemia of pregancy
EP0005333B1 (fr) Composition pharmaceutique contenant un amino-acide pour réduire le taux de prolactine dans le sérum sanguin
SENGA et al. Comparison of peripheral thyroid hormone metabolism in normal rats and in rats receiving prolonged glucagon infusion
Vasilakes et al. Annotated Semantic Predications from SemMedDB
US7919533B2 (en) Diiodothyroacetic acid and method of use
AU597561B2 (en) Method of changing the rate of oxidation of amines in vertebrates and other organisms
CA1277902C (fr) Methode pour abaisser le taux de sucre dans le sang des vertebres
MILLER et al. Modulating influence of D, L-Propranolol on triiodothyronine-induced skeletal muscle protein degradation